Clinical trial Recruiting at 3 sites Observational Ages 18 to 75

Identifying blood biomarkers for obstructive sleep apnea using microRNAs

Official title: MicroRNAs as Biomarkers for Obstructive Sleep Apnea

Run by University of Pennsylvania · NCT06189755 · Data updated 2026-11-12

This study is testing if certain blood markers can help identify obstructive sleep apnea in people by looking at tiny molecules called microRNAs.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment500 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations3 sites (Columbus, Ohio and 2 other locations)
StatusRecruiting
StartedApril 1, 2024
Main results expectedNovember 1, 2027
Study endsApril 30, 2028
Registry record updatedAugust 3, 2026
Trial IDNCT06189755 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18-75 with moderate to severe obstructive sleep apnea who are willing to accept positive airway pressure therapy.

Probably not a fit

Patients currently using positive airway pressure therapy or with certain medical conditions, such as chronic kidney disease requiring dialysis, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop and validate blood biomarkers specific to obstructive sleep apnea (OSA) by analyzing microRNAs. The research will compare microRNA profiles between individuals with moderate to severe OSA and healthy controls matched for age, sex, and body mass index. The study will utilize sequencing techniques and quantitative PCR to assess microRNA expression, which may help improve case identification, monitor therapy efficacy, and predict blood pressure responses to treatment. By establishing these biomarkers, the study seeks to enhance the management of OSA patients.

Why it matters

Potential benefit: If successful, this study could lead to improved identification and management of obstructive sleep apnea through the use of specific blood biomarkers.

How similar studies have gone: Previous studies have suggested differences in microRNA expression between OSA cases and controls, indicating potential success for this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for Cases:

* age 18-75 years
* moderate-severe OSA (defined as AHI ≥15 events/hour)
* willing to accept PAP therapy

Inclusion Criteria for Controls:

* age 18-75 years
* no OSA (defined as AHI \<5 events/hour)

Exclusion Criteria for Cases:

* current use of PAP or other OSA treatments
* home oxygen therapy
* recent changes (within 3 months) to BP medications among those who are on these medications
* presence of Cheyne-Stokes Respiration (CSR) in sleep study
* predominantly central sleep apnea (AHI≥15 events/hour, with \>50% central events)
* pregnancy
* clinical history of chronic kidney disease (Stage 5) requiring dialysis, or renal transplant
* organ transplantation
* self-reported sleep duration less than 5 hours per night on weeknights (work nights)
* current night shift work

Exclusion Criteria for Controls:

* home oxygen therapy
* pregnancy
* clinical history of chronic kidney disease (Stage 5) requiring dialysis, or renal transplant
* organ transplantation
* self-reported sleep duration less than 5 hours per night on weeknights (work nights)
* current night shift work

Where it's running

  • The Ohio State University - Martha Morehouse Medical Pavilion, Suite 2600
    Columbus, Ohio, United States
    Recruiting
  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting
  • University of Iceland
    Reykjavik, Iceland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.